Genomics: Funding, Investors & Team (Oct 2026)
The goal of Genomics plc is to take the lead in revolutionizing healthcare through genomics. They aim to utilize complex analyses of large sets of combined genetic and observable data to gain insights into human biology and uncover the blueprint of human genetics. With their expertise and experience, they intend to pave the way in this field, unlocking the full potential of genomics and establishing the benchmarks for organizations and patients to utilize genomic data effectively.
Genomics has raised $44.5M across 1 funding round on record, the most recent a Series C of $44.5M announced in Jan 2024.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Genomics Company Profile and Key Stats
Latest funding round on record: Jan 2024.
Genomics Funding Rounds
Genomics Founders and Leadership Team
No contact details are on record for this team yet.
Genomics Funding Compared to Other Biotechnology Startups
Genomics' latest round of $44.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Genomics in Biotechnology and Oxford
Companies Similar to Genomics
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…
Argonaute RNA company research projects build on existing intellectual property.
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
Genomics Funding FAQs
What does Genomics do?
The goal of Genomics plc is to take the lead in revolutionizing healthcare through genomics. They aim to utilize complex analyses of large sets of combined genetic and observable data to gain insights into human biology and uncover the blueprint of human genetics. With their expertise and experience, they intend to pave the way in this field, unlocking the full potential of genomics and establishing the benchmarks for organizations and patients to utilize genomic data effectively.
How much funding has Genomics raised?
Genomics has raised $44.5M across 1 round on record. The most recent is a Series C of $44.5M announced in Jan 2024.
When did Genomics last raise funding?
Genomics' most recent funding round on record is a Series C of $44.5M, announced in Jan 2024.
Who founded Genomics?
FundedIQ lists Peter Donnelly (Founder) at Genomics.
Where is Genomics headquartered?
Genomics is based in Oxford, Oxfordshire, United Kingdom.
How many employees does Genomics have?
Genomics is in the 101-250 employee band.
How does Genomics' funding compare to other Biotechnology startups?
Genomics' latest round of $44.5M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Genomics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Genomics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.